loading

Finanzdaten der Astria Therapeutics Inc-Aktie (ATXS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.18%
35.82
36.99 29.59 29.01 28.80
Operating Income/Loss
3.18%
-35.82
-36.99 -29.59 -29.01 -28.80
Nonoperating Income/Loss
15.76%
2.768
3.286 3.965 4.48 4.631
Income/Loss From Continuing Operations Before Tax
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Income/Loss From Continuing Operations After Tax
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Net Income/Loss
1.95%
-33.05
-33.71 -25.63 -24.53 -24.17
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
58.01
58.01 0.6192 57.82 56.49
Diluted Average Shares
0.00%
58.01
58.01 0.6192 57.82 56.49
Basic Earnings Per Share
1.72%
-0.57
-0.58 -0.44 -0.42 -0.43
Diluted Earnings Per Share
1.72%
-0.57
-0.58 -0.44 -0.42 -0.43
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Kapitalisierung:     |  Volumen (24h):